
|Articles|April 30, 2020
Keeping a step ahead of the disease: proactive treatment for nAMD
Advertisement
Download Supplement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
SubscribeAdvertisement
Latest CME
Advertisement
Advertisement
Trending on Eye Care Network - Ophthalmology Times
1
FDA grants RMAT designation to Emmecell's EO2002 for corneal endothelial disease
2
Opus Genetics reaches FDA alignment on phase 3 registrational design for OPGx-LCA5 gene therapy
3
Eyes on June 2026: Approvals, pipeline momentum, and AI under the microscope
4
Understanding meibomian gland dysfunction, neuropathic pain, and the evolving dry eye patient
5






















